2013 Senate Bill 660 ↩

Senate Roll Call 516: The amendment was not adopted

To exclude "pharmaceutical cannabis" from the liability waiver of a tort reform law passed in 1995, under which lawsuits against prescription drug makers are prohibited unless the company intentionally withheld information or misled the FDA about the drug, or used bribery to gain approval.